A Prospective Interventional Comparative Long-Term Study on the Safety of Canagliflozin and Dapagliflozin Depending on their ADR’s and Glucose Monitoring Parameters in a Tertiary Care Hospital for a Span of One Year

A Prospective Interventional Comparative Long-Term Study on the Safety of Canagliflozin and Dapagliflozin Depending on their ADR’s and Glucose Monitoring Parameters in a Tertiary Care Hospital for a Span of One Year Department of Pharmacology, Vels institute of Science, Technology and Advanced Studies (VISTAS), Chennai-600117, Tamil Nadu, India Dhanush Bellapu Ronald Darwin Department of Pharmacology, Vels institute of Science, Technology and Advanced Studies (VISTAS), Chennai-600117, Tamil Nadu, India

Introduction: SGLT2 inhibitors have a wide extent of restorative movement and higher chance of hypoglycaemia because of their affront autonomous action in treating type-2 Diabetes. SGLT2 inhibitors have great security and resistance when utilized as monotherapy or in conjunction with other oral hypoglycaemic medicines. Since SGLT2 inhibitors can cause hyperglycaemia, which results in vaginal and UTI contaminations. When compared, Dapagliflozin had higher contaminations. The key issue displayed is that ketoacidosis and that it may take a little time to analyse it. Objectives: A careful comparison of Canagliflozin vs Dapagliflozin in terms of long-term urinary volume, renal function, and metabolic changes suggests that both are effective, but Dapagliflozin may have a slightly safer profile regarding fluid balance and tolerance in vulnerable populations. However, individual patient factors (e.g., baseline renal function, risk of volume depletion) must guide the choice. Research methodology: A Planned Interventional Comparative Ponder conducted among 3452 patients who were conceded to in the General Medicine and Endocrine Departments, Anu Group of hospitals, Vijayawada over 12 months from December 2021 to December 2022. By alluding to the patient’s FBS and PPBS, RFT, HbA1c, BP, and the finding seriousness score of ADR (Adverse Drug Reaction) utilizing Naranjo scale. Results: Patients had most common ADRs after Utilizing Canagliflozin and Dapagliflozin, were Hypotension and Dehydration respectively. Conclusion: We concluded that in Patients had ADRs after utilizing Canagliflozin versus Dapagliflozin where hypotension and dehydration was more common respectively. ADRs in the Control population was weight pick up had the negative impact and Hypoglycaemia was found to be more in the Control population compared to Canagliflozin and Dapagliflozin endorsed bunches. Weight loss had a positive impact on Canagliflozin and Dapagliflozin-endorsed groups.
2025 01 06 10.25258/ijddt.15.2.49 https://impactfactor.org/PDF/IJDDT/15/IJDDT,Vol15,Issue2,Article49.pdf